Resting state electroencephalographic correlates with red cell long-chain fatty acids, memory performance and age in adolescent boys with attention deficit hyperactivity disorder

Neuropharmacology

Volumn 57, Issue 7-8, 2009, Pages 708-714

  Sumich, Alexander ^a   Matsudaira, Toshiko ^a   Gow, Rachel V ^a   Ibrahimovic, Almira ^a   Ghebremeskel, Kebreab ^b   Crawford, Michael ^b   Taylor, Eric ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Attention deficit and hyperactivity disorder (ADHD); Electroencephalography; Fatty acids; Memory; Neurobiology; Verbal fluency

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADOLESCENT; AGE DISTRIBUTION; ALPHA RHYTHM; ARTICLE; ATTENTION DEFICIT DISORDER; BETA RHYTHM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ERYTHROCYTE LEVEL; FATTY ACID ANALYSIS; HUMAN; MALE; MEMORY; NEUROBIOLOGY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RECALL; REST; SCHOOL CHILD; SEMANTIC MEMORY; THETA RHYTHM; VERBAL MEMORY;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; EICOSAPENTAENOIC ACID; ELECTROENCEPHALOGRAPHY; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; REST;

EID: 70350364629     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.07.024     Document Type: Article

References (68)

1. Ahnaou A., Nayak S., Heylen A., Ashton D., and Drinkenburg W.H. Sleep and EEG profile in neonatal hippocampal lesion model of schizophrenia. Physiol. Behav. 92 3 (2007) 461-467
2. Arns M., Gunkelman J., Breteler M., and Spronk D. EEG phenotypes predict treatment outcome to stimulants in children with ADHD. J. Integr. Neurosci. 7 3 (2008) 421-438
3. Arruda J.E., Amoss R.T., Coburn K.L., and McGee H. A quantitative electroencephalographic correlate of sustained attention processing. Appl. Psychophysiol. Biofeedback 32 1 (2007) 11-17
4. Antalis C.J., Stevens L.J., Campbell M., Pazdro R., Ericson K., and Burgess J.R. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot. Essent. Fatty Acids 75 4-5 (2006) 299-308
5. Ariel A., and Serhan C.N. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 28 (2007) 176-183
6. Babiloni C., Pievani M., Vecchio F., Geroldi C., Eusebi F., Fracassi C., Fletcher E., De Carli C., Boccardi M., Rossini P.M., and Frisoni G.B. White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment. Hum. Brain Mapp. 30 5 (2009) 1431-1443
7. Banaschewski T., Hollis C., Oosterlaan J., Roeyers H., Rubia K., Willcutt E., and Taylor E. Towards an understanding of unique and shared pathways in the psychopathophysiology of ADHD. Dev. Sci. 8 2 (2005) 132-140
8. Barry R.J., Clarke A.R., and Johnstone S.J. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin. Neurophysiol. 114 2 (2003) 171-183
9. Burgess J.R., Stevens L., Zhang W., and Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 71 Suppl. 1 (2000) 327S-330S
10. Calder P.C. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 77 5-6 (2007) 327-335
11. Calderon F., and Hee-Yong K. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem. 90 4 (2004) 979-988
12. Campbell I.G., and Feinberg I. Longitudinal trajectories of non-rapid eye movement delta and theta EEG as indicators of adolescent brain maturation. Proc. Natl. Acad. Sci. U. S. A. 106 13 (2009) 5177-5180
13. Clark C.R., Paul R.H., Williams L.M., Arns M., Fallahpour K., Handmer C., and Gordon E. Standardized assessment of cognitive functioning during development and aging using an automated touchscreen battery. Arch. Clin. Neuropsychol. 21 5 (2006) 449-467
14. Chen J.R., Hsu S.F., Hsu C.D., Hwang L.H., and Yang S.C. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J. Nutr. Biochem. 15 8 (2004) 467-472
15. Conners C.K., Sitarenios G., Parker J.D., and Epstein J.N. Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity. J. Abnorm. Child Psychol. 26 4 (1998) 279-291
16. Conners C.K., Sitarenios G., Parker J.D., and Epstein J.N. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J. Abnorm. Child Psychol. 26 4 (1998) 257-268
17. Crawford M.A. Docosahexaenoic acid in neural signaling systems. Nutr. Health 18 3 (2006) 263-276
18. Dige N., Maahr E., and Backenroth-Ohsako G. Memory tests in subgroups of adult attention deficit hyperactivity disorder reveals simultaneous capacity deficit. Int. J. Neurosci. 118 4 (2008) 569-591
19. Ernst M., Kimes A.S., London E.D., Matochik J.A., Eldreth D., Tata S., Contoreggi C., Leff M., and Bolla K. Neural substrates of decision making in adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 160 6 (2003) 1061-1070
20. Fedorova I., and Salem Jr. N. Omega-3 fatty acids and rodent behavior. Prostaglandins Leukot. Essent. Fatty Acids 75 4-5 (2006) 271-289
21. Folch M., Lees G.H., and Sloane-Stanley A. Simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226 (1957) 497-509
22. Fontani G., Corradeschi F., Felici A., Alfatti F., Migliorini S., and Lodi L. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur. J. Clin. Invest. 35 11 (2005 Nov) 691-699
23. Garland M.R., and Hallahan B. Essential fatty acids and their role in conditions characterised by impulsivity. Int. Rev. Psychiatry 18 2 (2006) 99-105
24. Gorjão R., Azevedo-Martins A.K., Rodrigues H.G., Abdulkader F., Arcisio-Miranda M., Procopio J., and Curi R. Comparative effects of DHA and EPA on cell function. Pharmacol. Ther. 122 1 (2009) 56-64
25. Gow R.V., Matsudaira T., Taylor E., Rubia K., Crawford M., Ghebremeskel K., Ibrahimovic A., Vallée-Tourangeau F., Williams L.M., and Sumich A. Total red blood cell concentrations of omega-3 fatty acids are associated with emotion-elicited neural activity in adolescent boys with attention-deficit hyperactivity disorder. Prostaglandins Leukot. Essent. Fatty Acids 80 2-3 (2009) 151-156
26. Harding K.L., Judah R.D., and Gant C. Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD. Altern. Med. Rev. 8 3 (2003) 319-330
27. Harris W.S. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol. Res. 55 3 (2007) 217-223
28. Hayaishi O. Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355 1394 (2000) 275-280
29. Hermens D.F., Williams L.M., Lazzaro I., Whitmont S., Melkonian D., and Gordon E. Sex differences in adult ADHD: a double dissociation in brain activity and autonomic arousal. Biol. Psychol. 66 3 (2004) 221-233
30. Hirayama S., Hamazaki T., and Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study. Eur. J. Clin. Nutr. 58 3 (2004) 467-473
31. Jazayeri S., Tehrani-Doost M., Keshavarz S.A., Hosseini M., Djazayery A., Amini H., Jalali M., and Peet M. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Am. N. Z. J. Psychiatry 42 (2008) 192-198
32. Johnson M., Ostlund S., Fransson G., Kadesjö B., and Gillberg C. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J. Atten. Disord. 12 5 (2009) 394-401
33. Joshi K., Lad S., Kale M., Patwardhan B., Mahadik S.P., Patni B., Chaudhary A., Bhave S., and Pandit A. Supplementation with flax oil and vitamin C improves the outcome of attention deficit hyperactivity disorder (ADHD). Prostaglandins Leukot. Essent. Fatty Acids 74 1 (2006) 17-21
34. Kaufman A.S., and Kaufman N.L. Kaufman Adolescent and Adult Intelligence Test (1993), American GuidanceService, CirclePines, MN
35. Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res. Brain Res. Rev. 29 2-3 (1999) 169-195
36. Klimesch W. Memory processes, brain oscillations and EEG synchronization. Int. J. Psychophysiol. 24 1-2 (1996) 61-100
37. Lazzaro I., Gordon E., Li W., Lim C.L., Plahn M., Whitmont S., Clarke S., Barry R.J., Dosen A., and Meares R. Simultaneous EEG and EDA measures in adolescent attention deficit hyperactivity disorder. Int. J. Psychophysiol. 34 2 (1999) 123-134
38. Loo S.K., Hopfer C., Teale P.D., and Reite M.L. EEG correlates of methylphenidate response in ADHD: association with cognitive and behavioral measures. J. Clin. Neurophysiol. 21 6 (2004) 457-464
39. Plessen K.J., Bansal R., Zhu H., Whiteman R., Amat J., Quackenbush G.A., Martin L., Durkin K., Blair C., Royal J., Hugdahl K., and Peterson B.S. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 63 7 (2006 Jul) 795-807
40. Richardson A.J. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int. Rev. Psychiatry 18 2 (2006) 155-172
41. Richardson A.J., and Montgomery P. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 115 5 (2005) 1360-1366
42. Rooney M.T., Fristad M.A., Weller E.B., and Weller R.A. Administration Manual for the ChIPS (1999), American Psychiatric Publishing, Washington, DC
43. Rubia K., Smith A.B., Halari R., Matsukura F., Mohammad M., Taylor E., and Brammer M.J. Disorder-specific dissociation of orbitofrontal dysfunction in boys with pure conduct disorder during reward and ventrolateral prefrontal dysfunction in boys with pure ADHD during sustained attention. Am. J. Psychiatry 166 1 (2009) 83-94
44. Rubia K., Smith A.B., Brammer M.J., and Taylor E. Temporal lobe dysfunction in medication-naïve boys with attention-deficit/hyperactivity disorder during attention allocation and its relation to response variability. Biol. Psychiatry 62 9 (2007) 999-1006
45. Saugstad L.F. What is a psychosis and where is it located?. Eur. Arch. Psychiatry Clin. Neurosci. 258 Suppl. 2 (2008) 111-117
46. Saugstad L.F. Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with adequate dietary omega-3?. Nutr. Health 18 3 (2006) 203-215
47. Salem Jr. N., Litman B., Kim H.Y., and Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36 9 (2001) 945-959
48. Sergeant J.A., Geurts H., Huijbregts S., Scheres A., and Oosterlaan J. The top and the bottom of ADHD: a neuropsychological perspective. Neurosci. Biobehav. Rev. 27 7 (2003) 583-592
49. Serhan C.N., Gotlinger K., Hong S., and Arita M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 73 (2004) 155-172
50. Sergeant J.A., Geurts H., and Oosterlaan J. How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder?. Behav. Brain Res. 130 1-2 (2002) 3-28
51. Sinn N., Bryan J., and Wilson C. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial. Prostaglandins Leukot. Essent. Fatty Acids 78 4-5 (2008) 311-326
52. Sinn N., and Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J. Dev. Behav. Pediatr. 28 2 (2007) 82-91
53. Su K.P. Biological mechanism of antidepressant effect of Omega-3 fatty acids: how does fish oil act as a 'mind-body interface'?. Neurosignals 17 2 (2009) 144-152
54. Su K.P. Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression. Asia Pac. J. Clin. Nutr. 17 Suppl. 1 (2008) 151-157
55. Smith A.B., Taylor E., Brammer M., Halari R., and Rubia K. Reduced activation in right lateral prefrontal cortex and anterior cingulate gyrus in medication-naïve adolescents with attention deficit hyperactivity disorder during time discrimination. J. Child Psychol. Psychiatry 49 9 (2008) 977-985
56. Sumich, A., Ibrahimovic, A., Matsudaira, T., Gow, R.V., Crawford, M.A., Taylor, E., 2008a. Association between blood levels of omega-3 fatty acids personality in adolescent boys with attention deficit and hyperactivity disorder: abstract (P112) presented at the International Society for the Study of Fatty Acids and Lipids (ISSFAL) conference.
57. Sumich, A., Gow, R.V., Matsudaira, T., Ibrahimovic, A., Crawford, M.A., Taylor, E., 2008b. Association between blood levels of omega-3 fatty acids and cognition in adolescence with attention deficit and hyperactivity disorder: verbal intelligence and memory. Abstract (P115) presented at the International Society for the Study of Fatty Acids and Lipids (ISSFAL) conference.
58. Suzuki H., Manabe S., Wada O., and Crawford M.A. Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice. Int. J. Vit. Res. 67 (1997) 272-278
59. Stevens L., Zhang W., Peck L., Kuczek T., Grevstad N., Mahon A., Zentall S.S., Arnold L.E., and Burgess J.R. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids 38 10 (2003) 1007-1021
60. Takeuchi T., Fukumoto Y., and Harada E. Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. Behav. Brain Res. 131 1-2 (2002) 193-203
61. Talk A., Kang E., and Gabriel M. Independent generation of theta rhythm in the hippocampus and posterior cingulate cortex. Brain Res. 1015 1-2 (2004) 15-24
62. Tassoni D., Kaur G., Weisinger R.S., and Sinclair A.J. The role of eicosanoids in the brain. Asia Pac. J. Clin. Nutr. 17 Suppl. 1 (2008) 220-228
63. Uauy R., and Dangour A.D. Nutrition in brain development and aging: role of essential fatty acids. Nutr. Rev. 64 5 Pt 2 (2006) S24-S33 (discussion S72-S91)
64. Voigt R.G., Llorente A.M., Jensen C.L., Fraley J.K., Berretta M.C., and Heird W.C. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J. Pediatr. 139 2 (2001) 189-196
65. Whalley L.J., Fox H.C., Wahle K.W., Starr J.M., and Deary I.J. Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am. J. Clin. Nutr. 80 6 (2004) 1650-1657
66. Whitford T.J., Rennie C.J., Grieve S.M., Clark C.R., Gordon E., and Williams L.M. Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology. Hum. Brain Mapp. 28 3 (2007) 228-237
67. Williams L.M., Simms E., Clark C.R., Paul R.H., Rowe D., and Gordon E. The test-retest reliability of a standardized neurocognitive and neurophysiological test battery: "neuromarker". Int. J. Neurosci. 115 (2005) 1605-1630
68. Young G.S., Maharaj N.J., and Conquer J.A. Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids 39 2 (2004) 117-123